977
Views
11
CrossRef citations to date
0
Altmetric
Review Articles

Remineralization potential and caries preventive efficacy of CPP-ACP/Xylitol/Ozone/Bioactive glass and topical fluoride combined therapy versus fluoride mono-therapy – a systematic review and meta-analysis

, ORCID Icon, &
Pages 402-417 | Received 23 Jul 2020, Accepted 21 Dec 2020, Published online: 16 Jan 2021
 

Abstract

Objective

To compare the remineralization potential and caries preventive efficacy of CPP-ACP/bioactive glass/xylitol/ozone and topical fluoride (TF) combined therapy versus TF mono-therapy.

Material and methods

Embase, PubMed, Scopus, Web of Science and Cochrane databases were searched. 4457 records were screened and 26 trials were included. Data from 16 trials was pooled using Review Manager 5.4. Level of significance was p < .05. The certainty of the evidence was evaluated using GRADE.

Results

Pooled analysis of two trials for white spot lesions (WSLs) regression (SMD −0.6, 95% CI: [−1.07 to −0.14], p = .01) and three trials for post-intervention DIAGNOdent values (SMD −1.24, 95% CI: [−1.96 to −0.52], p = .0007) significantly favoured CPP-ACP-TF combined therapy over TF mono-therapy. The sub-group analysis for caries increment (SMD −0.14, 95% CI: [−0.21 to −0.07], p < .0001) and the post intervention S mutans count (SMD −0.42, 95% CI: [−0.62 to −0.23], p < .0001) significantly favours ‘xylitol-TF’ and ‘CPP-ACP-TF’ combined therapy respectively. The high/unclear risk of bias, imprecision and indirectness of the included trials presented a low certainty of evidence.

Conclusion

CPP-ACP-TF exhibits superiority over TF monotherapy in remineralizing existing lesions and demonstrates better antibacterial effect, whereas it is not more effective for preventing caries incidence. However, Xylitol exerts an added benefit over fluoride alone in preventing caries increment. The low-certainty evidence highlights the need for more good quality trials.

Disclosure statement

The authors declare no potential conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.